Belongs to

• Center for Hematologic Malignancies

Types of Work

["2019"]

[[["Journal Articles",1360],["Meeting Abstracts",1277],["Reviews",74],["Book Sections",38],["Editorials",34],["Research Letters",27],["Conference Papers",14],["Guidelines",14],["Correspondences",6],["Miscellaneous",2],["Books Whole",1]]]

[2847]

Popular keywords

• adult
• aged
• article
• controlled study
• female
• human
• human cell
• male
• nonhuman
• priority journal

Recent Works

1. Pirtobrutinib, a highly selective, non-covalent (reversible) BTK inhibitor in previously treated mantle cell lymphoma: Updated results from the phase 1/2 BRUIN study

   Meeting Abstract

   Wang, M.; Shah, N.; Alencar, A.; Gerson, J.; Patel, M.; Fakhri, B.; Jurczak, W.; Tan, X.; Lewis, K.; Fenske, T.; more...
   British Journal of Haematology (2022)

   Fulltext@MSK | Save
2. Exploratory analysis: Potential of pelabresib (CPI-0610), a bromodomain and extra-terminal domain inhibitor, as suggested by analysis of improvements in bone marrow histology and function in patients with myelofibrosis-preliminary data

   Meeting Abstract

   Harrison, C.; Verstovsek, S.; Salama, M. E.; Mascarenhas, J.; Talpaz, M.; Mesa, R.; Vannucchi, A. M.; Rampal, R. K.; Oh, S.; Olteanu, H.; more...
   British Journal of Haematology (2022)

   Fulltext@MSK | Save
3. Pelabresib (CPI-0610) monotherapy in patients with myelofibrosis - Update of clinical and translational data from the ongoing MANIFEST trial

   Meeting Abstract

   Curto-Garcia, N.; Kremyanskaya, M.; Mascarenhas, J.; Palandri, F.; Vannucchi, A. M.; Verstovsek, S.; Harrison, C.; Bose, P.; Schiller, G. J.; Rampal, R.; more...
   British Journal of Haematology (2022)

   Fulltext@MSK | Save